Evidence map›Paper›PMID 42064099›Full record

ArticleFrontiers in bioengineering and biotechnology2026

Phytosynthesis of Ag@AgCl nanoparticles using two types of bionanotechnological protocols exhibiting unique antimicrobial, antioxidant, and anti-inflammatory properties.

Yoshinee Doongoor, Joyce G Soulange, Marek Kolenčík

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yoshinee DoongoorFaculty of Agriculture, University of Mauritius, Reduit, Mauritius.
Joyce G SoulangeFaculty of Agriculture, University of Mauritius, Reduit, Mauritius.
Marek KolenčíkInstitute of Agrochemistry and Soil Science, Faculty of Agrobiology and Food Resources, Slovak University of Agriculture in Nitra, Nitra, Slovakia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The synthesis of nanomaterials aims to integrate scientific innovation with a commitment to address the UN's Sustainable Development Goals (SDGs). Our study reports two biotechnological protocols for the synthesis of colloidal Ag@ AgCl nanoparticles (Ag@AgCl-NPs) using the endemic Mauritian herb Methods: The Ag-based nanoparticles (NPs) containing colloids and extracts were tested for antimicrobial, antioxidant, and anti-inflammatory activities. The successful bottom-up phytosynthesis of Ag@AgCl-NPs was characterized by transmission electron microscopy (TEM) with chemical verification using energy-dispersive X-ray spectroscopy (EDS), crystallinity assessment using X-ray diffraction (XRD), UV-VIS and Fourier transform-infrared (FT-IR) spectroscopy, and investigation of colloidal properties. Green synthesis approaches favored NP formation and colloidal stability. Antimicrobial activity was tested against Gram-positive (G+) and Gram-negative (G-) bacteria and fungi using the broth microdilution assay. Antioxidant activity was determined by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method, while anti-inflammatory activity was examined using the bovine serum albumin (BSA) test. Results: Our results confirmed the successful green bionanotechnological synthesis of Ag@AgCl-NPs with varying relative mass ratios, exhibiting spherical morphology and good crystallinity. Additionally, both colloids with Ag@AgCl-NPs exhibited exceptional synergistic antimicrobial effects against highly resistant G+ and G- bacterial pathogens and the yeast Discussion: Thus, eco-friendly phytosynthesis from

Indexed as

Ag@AgCl nanoparticlesanti-inflammatoryantimicrobial activityantioxidantbionanotechnologyPsiadia terebinthina

Identifiers

PMID42064099
PMCPMC13124941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.